Viewing Study NCT05246293


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-01-01 @ 4:33 AM
Study NCT ID: NCT05246293
Status: UNKNOWN
Last Update Posted: 2023-04-27
First Post: 2022-01-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
Sponsor: National Institute of Respiratory Diseases, Mexico
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2024-03-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-03-02
Completion Date Type: ESTIMATED
First Submit Date: 2022-01-17
First Submit QC Date: None
Study First Post Date: 2022-02-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-26
Last Update Post Date: 2023-04-27
Last Update Post Date Type: ACTUAL